CD14+ monocytes as dendritic cell precursors: Diverse maturation-inducing pathways lead to common activation of NF-κB/RelB

Critical Reviews in Immunology

Volumn 21, Issue 1-3, 2001, Pages 179-189

  Koski, G K ^a   Lyakh, L A ^a   Cohen, P A ^a   Rice, N R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dendritic cell; Intracellular signaling; Maturation; Nuclear factor kappa B

Indexed keywords

CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTIGEN PRESENTING CELL; CELL ACTIVITY; CELL CULTURE; CELL MATURATION; CONFERENCE PAPER; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; ANTIGENS, CD14; CALCIUM; CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; IMMUNITY, NATURAL; MONOCYTES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS;

EID: 0034799735     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (58)

1. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells
2. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins
3. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ
4. Myeloid dendritic cells
5. Antigen capture, processing, and presentation by dendritic cells: Recent cell biological studies
6. HLA-DR-positive leucocyte subpopulations in human skin include dendritic cells, macrophages, and CD7-negative T cells
7. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization
8. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies
9. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
10. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo
11. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells
12. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes
13. Epidermal Langerhans cells are derived from cells originating in bone marrow
14. Bone marrow origin of Ia-positive cells in the medulla rat thymus
15. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
16. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha
17. + hematopoietic precursor cells
18. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages
19. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha
20. Proliferating dendritic cell progenitors in human blood
21. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
22. + dendritic cells
23. Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells
24. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia
25. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide
26. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells
27. Dendritic cells as the terminal stage of monocyte differentiation
28. Expression of relB transcripts during lymphoid organ development: Specific expression in dendritic antigen-presenting cells
29. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family
30. + dendritic cells
31. Expression of relB is required for the development of thymic medulla and dendritic cells
32. Expression of the RelB transcription factor correlates with the activation of human dendritic cells
33. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells
34. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells
35. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells
36. The NF-kappa B and I kappa B proteins: New discoveries and insights
37. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity
38. Dendritic cells
39. Activators and target genes of Rel/NF-kappaB transcription factors
40. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
41. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
42. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
43. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
44. The Toll-receptor family and control of innate immunity
45. Multiple signals converging on NF-kappaB
46. The IKK complex: An integrator of all signals that activate NF-kappaB?
47. Tumor necrosis factor receptor-associated factor (TRAF) family: Adapter proteins that mediate cytokine signaling
48. Calcium ionophore A23187 induces interleukin 2 reactivity in human T cells
49. Synergistic action of A23187 and phorbol ester on human B cell activation
50. Calcium ionophore treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells
51. Calcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase
52. Calcium ionophore treated myeloid cells acquire many dendritic dell characteristics independent of prior differentiation state, transformation status or sensitivity to biologic agents
53. Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways
54. Recent advances in the mechanism of action of cyclosporine and FK506
55. + monocytes through distinct pathways that activate NF-κB
56. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
57. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo
58. Composition of interstitial fluid